Raymond James maintains Outperform rating on Corpay stock
ArchivedSingle Source|1 articles|1 sources|1 blocks
Detected: Updated: Analyzed:
Reported Facts
Observable data points shared across all narratives
- •Raymond James set a target price of $361 for Corpay stock.
- •The Outperform rating suggests expectations of Corpay's stock to perform better than the market average.
- •The rating and target price were reiterated on March 5, 2026.
What Could Happen If...
- ▸If Raymond James upgrades Corpay's rating to Strong Buy investor interest in Corpay stock could increase, potentially driving up its price.
Market Exposure
StocksCorpayUpward Pressure
Raymond James's Outperform rating and $361 target price may encourage buying activity in Corpay stock.
This is not investment advice. Market exposure is based on conditional event analysis.
Key Actors
Instruments
Organizations
Source Coverage
FINANCE
1 articles
More coverage on this story
- More on Corpay stock
- More on Corpay
- More on Raymond James
Signals
Single-block coverage
Related Events
▸Raymond James Lifts Home Bancorp Target on Margin GainsArchived▸Raymond James upgrades Oscar Health stock rating to OutperformArchived▸Raymond James downgrades Vertical Aerospace stock over funding concernsArchived▸Raymond James Reaffirms Strong Buy on Taysha Gene Therapies StockArchived▸Raymond James downgrades IPG Photonics stock to Outperform, raises price target